Newer quinolones able to tackle many ocular surface bacteria

April 15, 2004

Stanford, CA-In vitro susceptibility test results demonstrate that the newer, 8-methoxy fluoroquinolones gatifloxacin (Zymar, Allergan) and moxifloxacin (Vigamox, Alcon) outperform older fluoroquinolones in their activity against gram-positive ocular isolates, including those with resistance to multiple other antibiotics, said Herminia Mi?o de Kaspar, PhD, senior research associate, department of ophthalmology, Stanford University, Stanford, CA.